Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -8.84 |
peg ratio | -0.42 |
price to book ratio | 4.24 |
price to sales ratio | 129.85 |
enterprise value multiple | -13.00 |
price fair value | 4.24 |
profitability ratios | |
---|---|
gross profit margin | 89.58% |
operating profit margin | -1217.01% |
pretax profit margin | -1292.6% |
net profit margin | -1286.97% |
return on assets | -48.41% |
return on equity | -82.8% |
return on capital employed | -46.5% |
liquidity ratio | |
---|---|
current ratio | 58.27 |
quick ratio | 58.27 |
cash ratio | 54.21 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 201.89 |
days of payables outstanding | 1,127.79 |
cash conversion cycle | -925.90 |
receivables turnover | 1.81 |
payables turnover | 0.32 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.01 |
debt equity ratio | 0.01 |
long term debt to capitalization | 0.01 |
total debt to capitalization | 0.01 |
interest coverage | -4,586,244.00 |
cash flow to debt ratio | -32.89 |
cash flow ratios | |
---|---|
free cash flow per share | -0.35 |
cash per share | 0.61 |
operating cash flow per share | -0.34 |
free cash flow operating cash flow ratio | 1.04 |
cash flow coverage ratios | -32.89 |
short term coverage ratios | -172.01 |
capital expenditure coverage ratio | -25.01 |
Frequently Asked Questions
Lexaria Bioscience Corp. (LEXXW) published its most recent earnings results on 12-07-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Lexaria Bioscience Corp. (NASDAQ:LEXXW)'s trailing twelve months ROE is -82.8%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Lexaria Bioscience Corp. (LEXXW) currently has a ROA of -48.41%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
LEXXW reported a profit margin of -1286.97% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 58.27 in the most recent quarter. The quick ratio stood at 58.27, with a Debt/Eq ratio of 0.01.